Standex International (SXI) Financials

Standex International logo
$233.19 +3.27 (+1.42%)
As of 03:34 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Standex International

Annual Income Statements for Standex International

This table shows Standex International's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
52 47 37 68 20 36 61 139 73 56 105
Consolidated Net Income / (Loss)
52 47 37 68 20 36 61 139 73 58 129
Net Income / (Loss) Continuing Operations
52 39 30 48 41 39 61 139 74 58 129
Total Pre-Tax Income
69 51 68 67 54 53 81 164 95 69 163
Total Operating Income
70 57 78 79 61 59 88 171 102 94 194
Total Gross Profit
252 216 226 235 215 241 270 285 282 315 372
Total Revenue
752 648 596 640 605 656 735 741 721 790 892
Operating Revenue
752 648 596 640 605 656 735 741 721 790 892
Total Cost of Revenue
499 432 370 405 389 415 465 456 439 475 520
Operating Cost of Revenue
499 432 370 405 389 415 465 456 439 475 520
Total Operating Expenses
182 159 148 155 155 182 182 114 180 222 178
Selling, General & Admin Expense
170 145 141 150 148 163 170 172 170 193 219
Other Operating Expenses / (Income)
7.46 0.00 0.00 0.50 0.00 0.00 5.75 -63 -0.16 0.00 -57
Restructuring Charge
4.23 14 7.18 4.36 6.43 4.41 6.02 4.39 11 28 16
Total Other Income / (Expense), net
-1.82 -5.96 -9.75 -13 -6.45 -6.47 -7.01 -7.14 -6.62 -25 -31
Interest Expense
2.87 4.04 8.03 11 7.48 5.99 5.87 5.41 4.54 24 31
Other Income / (Expense), net
1.05 -1.92 -1.72 -1.74 1.02 -0.47 -1.13 -1.74 -2.07 -0.81 0.07
Income Tax Expense
16 12 38 19 13 14 20 25 22 11 34
Net Income / (Loss) Discontinued Operations
-0.17 7.41 6.24 20 -21 -2.07 -0.09 -0.16 -0.52 -0.04 -0.14
Net Income / (Loss) Attributable to Noncontrolling Interest
- - - - - - - 0.00 0.00 1.92 24
Basic Earnings per Share
$4.11 $3.68 $2.88 $5.40 $1.64 $3.00 $5.13 $11.77 $6.22 $4.68 $8.69
Weighted Average Basic Shares Outstanding
12.68M 12.67M 12.70M 12.45M 12.38M 12.21M 11.97M 11.85M 11.85M 12.07M 12.12M
Diluted Earnings per Share
$4.08 $3.65 $2.86 $5.38 $1.63 $2.97 $5.06 $11.58 $6.14 $4.64 $8.67
Weighted Average Diluted Shares Outstanding
12.68M 12.67M 12.70M 12.45M 12.38M 12.21M 11.97M 11.85M 11.85M 12.07M 12.12M
Weighted Average Basic & Diluted Shares Outstanding
12.68M 12.67M 12.70M 12.45M 12.38M 12.21M 11.97M 11.85M 11.85M 12.07M 12.12M

Quarterly Income Statements for Standex International

This table shows Standex International's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
16 20 18 0.86 22 15 15 2.12 67 20 24
Consolidated Net Income / (Loss)
16 20 18 1.28 23 15 16 21 69 24 24
Net Income / (Loss) Continuing Operations
16 20 18 1.29 23 15 16 21 69 24 24
Total Pre-Tax Income
20 26 23 2.00 18 26 21 27 83 32 32
Total Operating Income
22 27 24 8.46 26 35 30 36 91 38 40
Total Gross Profit
68 69 70 71 82 91 90 92 92 97 103
Total Revenue
177 180 170 190 208 222 217 221 225 228 233
Operating Revenue
177 180 170 190 208 222 217 221 225 228 233
Total Cost of Revenue
109 111 100 118 125 131 127 129 133 131 129
Operating Cost of Revenue
109 111 100 118 125 131 127 129 133 131 129
Total Operating Expenses
46 42 46 63 56 57 61 57 1.11 60 63
Selling, General & Admin Expense
42 41 43 46 52 53 54 56 52 57 60
Other Operating Expenses / (Income)
0.11 0.27 - - - - 0.00 - -57 - 0.90
Restructuring Charge
4.57 1.29 2.93 17 4.13 3.96 6.43 1.06 5.50 3.26 1.40
Total Other Income / (Expense), net
-1.58 -1.57 -0.95 -6.47 -8.67 -8.65 -8.65 -8.40 -8.16 -5.44 -8.26
Interest Expense
0.95 1.30 0.98 5.58 8.36 9.02 8.91 7.91 7.33 6.56 7.22
Other Income / (Expense), net
-0.63 -0.27 0.03 -0.89 -0.31 0.36 0.27 -0.49 -0.83 1.12 -1.04
Income Tax Expense
4.33 5.89 4.96 0.71 -5.20 11 5.17 6.54 14 8.52 7.93
Net Income / (Loss) Discontinued Operations
-0.14 -0.10 0.01 -0.01 -0.05 0.01 -0.03 0.05 -0.12 -0.05 -0.06
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 - 0.00 0.42 0.85 - 0.74 19 1.54 3.07 0.00
Basic Earnings per Share
$1.34 $1.68 $1.54 $0.07 $1.83 $1.24 $1.26 $0.17 $5.56 $1.70 $2.00
Weighted Average Basic Shares Outstanding
11.77M 11.85M 11.79M 11.94M 11.99M 12.07M 12.01M 12.04M 12.05M 12.12M 12.07M
Diluted Earnings per Share
$1.33 $1.64 $1.53 $0.07 $1.81 $1.23 $1.25 $0.17 $5.55 $1.70 $1.98
Weighted Average Diluted Shares Outstanding
11.85M 11.85M 11.90M 12.03M 12.06M 12.07M 12.05M 12.06M 12.06M 12.12M 12.15M
Weighted Average Basic & Diluted Shares Outstanding
11.85M 11.85M 12.08M 11.90M 12.07M 12.07M 12.12M 12.12M 12.11M 12.12M 12.10M

Annual Cash Flow Statements for Standex International

This table details how cash moves in and out of Standex International's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Change in Cash & Equivalents
26 -33 21 -16 26 18 -32 91 -42 -50 74
Net Cash From Operating Activities
80 63 65 73 47 84 78 91 93 70 90
Net Cash From Continuing Operating Activities
81 51 52 73 55 82 78 91 93 70 90
Net Income / (Loss) Continuing Operations
52 39 30 48 41 39 61 139 74 58 129
Consolidated Net Income / (Loss)
52 47 37 68 20 36 61 139 73 58 129
Net Income / (Loss) Discontinued Operations
-0.17 7.41 6.24 20 -21 -2.07 -0.09 -0.16 -0.52 -0.04 -0.14
Depreciation Expense
18 18 25 29 32 33 30 28 28 35 39
Non-Cash Adjustments To Reconcile Net Income
14 6.44 3.04 4.02 6.11 22 12 -51 9.69 8.58 -47
Changes in Operating Assets and Liabilities, net
-3.04 -13 -6.46 -8.89 -25 -12 -25 -26 -18 -32 -31
Net Cash From Discontinued Operating Activities
-0.90 13 13 0.42 -7.44 1.72 -0.42 0.03 -0.69 -0.05 -0.35
Net Cash From Investing Activities
-29 -179 -32 -50 -0.62 -39 -31 42 -62 -503 43
Net Cash From Continuing Investing Activities
-32 -178 -29 -158 -21 -39 -31 42 -62 -503 43
Purchase of Property, Plant & Equipment
-18 -25 -24 -33 -22 -22 -24 -24 -20 -28 -25
Acquisitions
-14 -154 -10 -128 -0.62 -27 -13 0.00 -49 -479 0.00
Divestitures
- - - 0.00 0.00 12 0.00 67 7.77 0.00 68
Other Investing Activities, net
-0.42 0.11 1.82 -0.38 1.34 -1.73 4.01 -2.93 -0.27 3.80 0.01
Net Cash From Discontinued Investing Activities
2.80 -0.99 -2.97 108 20 0.00 0.00 0.00 0.00 0.00 0.00
Net Cash From Financing Activities
-21 85 -12 -38 -19 -32 -69 -40 -69 380 -57
Net Cash From Continuing Financing Activities
-21 85 -12 -38 -19 -32 -69 -40 -69 380 -57
Repayment of Debt
-75 -164 -165 -237 -105 -17 -25 -226 -25 -389 -110
Repurchase of Common Equity
-5.64 -7.81 -2.65 -33 -10 -21 -31 -26 -32 -9.91 -4.40
Payment of Dividends
-6.85 -7.85 -8.89 -9.83 -11 -11 -12 -13 -14 -15 -19
Issuance of Debt
65 264 164 242 107 17 0.00 225 0.00 792 75
Other Financing Activities, net
0.80 0.00 0.00 -0.91 -0.87 -0.36 -2.17 -1.17 1.53 2.23 1.69
Other Net Changes in Cash
- - 0.29 - -1.98 4.80 - - -3.33 3.69 -1.84
Cash Interest Paid
2.35 3.26 6.18 9.47 6.32 4.90 4.75 4.23 4.09 21 31
Cash Income Taxes Paid
25 20 22 24 19 17 18 26 28 28 38

Quarterly Cash Flow Statements for Standex International

This table details how cash moves in and out of Standex International's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-3.63 15 10 -43 -11 -5.27 -5.89 -1.66 6.73 75 -62
Net Cash From Operating Activities
24 29 18 9.06 9.54 33 17 21 12 40 16
Net Cash From Continuing Operating Activities
24 29 18 9.12 9.55 33 17 21 12 40 16
Net Income / (Loss) Continuing Operations
16 20 18 1.29 23 15 16 21 69 24 24
Consolidated Net Income / (Loss)
16 20 18 1.28 23 15 16 21 69 24 24
Net Income / (Loss) Discontinued Operations
-0.14 -0.10 0.01 -0.01 -0.05 0.01 -0.03 0.05 -0.12 -0.05 -0.06
Depreciation Expense
7.18 6.99 7.06 8.51 9.74 10 9.82 9.98 9.45 9.40 9.55
Non-Cash Adjustments To Reconcile Net Income
4.25 0.54 -4.32 0.71 -22 34 -7.55 -8.40 -64 33 4.43
Changes in Operating Assets and Liabilities, net
-2.92 1.51 -3.38 -1.39 -1.39 -26 -1.29 -1.51 -2.56 -25 -23
Net Cash From Discontinued Operating Activities
-0.08 -0.19 0.03 -0.06 -0.01 -0.01 0.02 -0.15 -0.16 -0.06 -0.08
Net Cash From Investing Activities
-16 -7.67 -6.31 -423 -64 -10 -6.36 -7.73 62 -5.11 -6.56
Net Cash From Continuing Investing Activities
-16 -7.67 -6.31 -423 -64 -10 -6.36 -7.73 62 -5.11 -6.56
Purchase of Property, Plant & Equipment
-5.18 -6.53 -6.73 -6.97 -6.07 -8.58 -6.42 -7.66 -5.59 -5.53 -6.56
Other Investing Activities, net
-0.27 - 0.41 3.49 -0.10 -0.44 0.06 -0.06 -0.42 0.44 0.00
Net Cash From Financing Activities
-8.53 -3.37 -6.27 376 41 -31 -15 -15 -67 40 -71
Net Cash From Continuing Financing Activities
-8.53 -3.37 -6.27 376 41 -31 -15 -15 -67 40 -71
Repayment of Debt
- - 0.00 -339 -23 -27 -8.00 -18 -79 -5.00 -8.00
Repurchase of Common Equity
-5.13 -0.04 -4.38 -5.20 - -0.32 -3.74 -0.06 -0.00 -0.60 -4.29
Payment of Dividends
-3.54 -3.53 -3.53 -3.83 -3.84 -3.84 -4.56 -4.97 -4.93 -4.45 -68
Issuance of Debt
- - - - 68 - 0.00 - 17 50 8.00
Other Financing Activities, net
- - 1.64 - - - 0.81 0.39 0.25 0.24 0.86
Effect of Exchange Rate Changes
-3.05 - - - - - - - - - 0.54
Cash Interest Paid
0.86 1.01 0.90 2.66 9.68 7.92 8.73 7.90 7.51 6.55 6.87
Cash Income Taxes Paid
5.73 8.23 5.48 0.77 11 11 5.72 10 10 12 13

Annual Balance Sheets for Standex International

This table presents Standex International's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Total Assets
690 868 917 922 931 962 934 1,025 1,005 1,567 1,586
Total Current Assets
356 361 384 334 332 374 379 483 430 481 552
Cash & Equivalents
122 89 110 93 119 136 105 196 154 105 179
Accounts Receivable
104 127 120 103 98 110 117 123 121 173 173
Inventories, net
105 119 104 76 85 92 105 99 87 130 129
Prepaid Expenses
4.78 8.40 10 22 19 24 45 34 22 14 27
Other Current Assets
- - - - - - - 31 45 59 44
Plant, Property, & Equipment, net
107 133 137 134 133 133 129 131 135 160 153
Total Noncurrent Assets
228 374 396 454 466 454 427 411 440 926 881
Goodwill
157 243 212 274 271 278 268 265 281 610 582
Intangible Assets
40 103 85 119 106 99 86 76 79 226 199
Noncurrent Deferred & Refundable Income Taxes
11 1.14 7.45 14 17 9.57 8.19 15 17 12 4.41
Other Noncurrent Operating Assets
19 27 30 25 71 68 65 56 63 78 95
Total Liabilities & Shareholders' Equity
690 868 917 922 931 962 934 1,025 1,005 1,567 1,586
Total Liabilities
320 459 466 458 469 456 435 417 384 827 830
Total Current Liabilities
134 160 161 142 123 144 151 141 128 167 230
Accounts Payable
77 96 79 54 55 75 75 69 63 88 80
Accrued Expenses
51 59 58 50 60 62 68 62 57 63 68
Current Deferred & Payable Income Tax Liabilities
4.70 4.78 6.05 5.74 7.43 7.24 8.48 10 7.50 16 17
Other Current Liabilities
- - - - - - - - - 0.00 64
Total Noncurrent Liabilities
186 299 305 316 346 312 284 277 256 660 601
Long-Term Debt
92 192 194 198 199 199 175 173 149 553 518
Other Noncurrent Operating Liabilities
10 11 26 0.00 147 113 109 103 107 108 83
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
- - - - - - - - 0.00 28 0.00
Total Equity & Noncontrolling Interests
370 409 451 464 462 506 499 607 622 712 755
Total Preferred & Common Equity
370 409 451 464 462 506 499 607 622 712 755
Total Common Equity
370 409 451 464 462 506 499 607 622 712 755
Common Stock
94 99 103 107 115 123 133 143 148 178 170
Retained Earnings
678 717 761 818 828 852 901 1,027 1,086 1,127 1,215
Treasury Stock
-284 -291 -292 -324 -333 -353 -382 -404 -430 -428 -431
Accumulated Other Comprehensive Income / (Loss)
-118 -116 -122 -137 -148 -116 -153 -158 -183 -165 -199

Quarterly Balance Sheets for Standex International

This table presents Standex International's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027
Period end date 3/31/2023 9/30/2023 12/31/2023 3/31/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026 9/30/2026
Total Assets
1,015 981 1,005 994 1,038 1,483 1,555 1,555 1,555 1,527 1,540
Total Current Assets
461 420 436 419 447 465 487 488 491 483 513
Cash & Equivalents
175 127 142 139 165 121 110 99 97 104 117
Accounts Receivable
121 127 126 121 119 153 170 167 177 180 169
Inventories, net
105 98 99 95 90 104 120 136 131 130 143
Prepaid Expenses
57 67 66 62 24 31 29 22 23 26 37
Other Current Assets
- - - - 50 56 58 64 63 43 48
Plant, Property, & Equipment, net
131 129 133 135 138 138 147 160 160 153 154
Total Noncurrent Assets
424 432 436 439 452 880 921 908 903 891 873
Goodwill
269 275 280 282 292 587 611 600 594 586 581
Intangible Assets
80 84 83 82 79 208 227 218 212 205 195
Noncurrent Deferred & Refundable Income Taxes
9.21 14 14 15 19 22 17 12 12 9.79 4.26
Other Noncurrent Operating Assets
65 59 59 60 62 64 67 78 86 91 93
Total Liabilities & Shareholders' Equity
1,015 981 1,005 994 1,038 1,483 1,555 1,555 1,555 1,527 1,540
Total Liabilities
410 387 384 375 380 800 840 820 810 728 762
Total Current Liabilities
131 132 131 122 126 138 143 170 171 158 161
Accounts Payable
68 62 64 58 67 73 76 88 88 77 79
Accrued Expenses
56 60 56 55 53 60 59 67 69 64 65
Current Deferred & Payable Income Tax Liabilities
7.37 9.90 11 8.45 6.61 5.18 7.17 15 14 17 16
Other Current Liabilities
- - - - - - - - - - 0.00
Total Noncurrent Liabilities
279 255 254 252 254 662 697 650 639 570 601
Long-Term Debt
173 149 149 149 149 534 579 545 535 473 518
Other Noncurrent Operating Liabilities
106 107 105 103 105 128 118 106 104 97 83
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
606 595 621 619 658 656 687 708 700 754 778
Total Preferred & Common Equity
606 595 621 619 658 656 687 708 700 754 778
Total Common Equity
606 595 621 619 658 656 687 708 700 754 778
Common Stock
139 141 143 147 150 174 177 179 182 184 173
Retained Earnings
1,010 1,043 1,058 1,070 1,101 1,098 1,116 1,138 1,136 1,199 1,235
Treasury Stock
-397 -421 -425 -430 -432 -428 -428 -431 -430 -430 -434
Accumulated Other Comprehensive Income / (Loss)
-147 -168 -156 -168 -161 -188 -178 -179 -188 -199 -197

Annual Metrics And Ratios for Standex International

This table displays calculated financial ratios and metrics derived from Standex International's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
DEI Shares Outstanding
- - - - - - - - - - 12,114,922.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 12,114,922.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 8.64
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-2.66% -13.80% -8.08% 7.46% -5.53% 8.55% 12.05% 0.78% -2.75% 9.64% 12.85%
EBITDA Growth
-6.89% -18.51% 39.34% 5.49% -12.31% -2.04% 27.11% 69.29% -35.39% 0.08% 81.23%
EBIT Growth
-9.94% -22.96% 38.94% 1.72% -20.82% -4.64% 48.51% 94.30% -41.15% -7.20% 108.81%
NOPAT Growth
-6.06% -18.47% -20.63% 65.15% -19.88% -5.75% 54.33% 117.45% -45.80% -0.29% 94.81%
Net Income Growth
-4.91% -10.59% -21.36% 85.54% -70.27% 80.67% 68.32% 126.40% -47.43% -21.06% 122.84%
EPS Growth
-4.45% -10.54% -21.64% 88.11% -69.70% 82.21% 70.37% 128.85% -46.98% -24.43% 86.85%
Operating Cash Flow Growth
25.43% -21.02% 2.34% 12.97% -35.59% 76.92% -7.02% 16.84% 2.04% -24.89% 28.69%
Free Cash Flow Firm Growth
375.99% -288.31% 171.97% -134.13% 254.90% -72.78% 401.11% 93.07% -63.11% -1,132.99% 149.91%
Invested Capital Growth
-4.22% 50.94% -11.37% 19.61% -0.59% 5.54% -0.04% 2.78% 5.30% 92.73% -7.84%
Revenue Q/Q Growth
-0.79% -11.48% -12.00% 64.22% -18.74% 5.99% 1.14% 0.49% -1.12% 5.59% 0.70%
EBITDA Q/Q Growth
-8.73% -7.15% 11.96% -3.00% -8.56% 15.34% -4.45% 5.10% -1.36% 9.72% 1.24%
EBIT Q/Q Growth
-11.30% -8.27% 14.07% -6.71% -12.86% 25.22% -4.73% 6.07% -1.54% 9.72% 1.88%
NOPAT Q/Q Growth
-8.01% -4.64% 7.37% 5.94% -14.11% 26.08% -1.84% 4.60% -0.29% 0.68% 4.31%
Net Income Q/Q Growth
-7.45% 4.38% -4.01% -0.33% -34.34% 49.74% -1.10% 5.22% -0.78% -6.64% 6.69%
EPS Q/Q Growth
-7.27% 4.29% -4.03% 0.19% -34.27% 0.00% 0.00% 3.67% 0.82% -8.12% 5.73%
Operating Cash Flow Q/Q Growth
-10.08% -2.09% 6.19% 18.72% -35.90% 14.69% -3.18% 13.81% -11.41% 7.54% 8.49%
Free Cash Flow Firm Q/Q Growth
-9.21% -36.08% 1,457.27% -183.69% -27.96% -48.27% 70.49% 0.52% -10.95% -3.29% 50.79%
Invested Capital Q/Q Growth
-9.52% -0.69% -18.20% -4.93% -2.99% 0.85% -4.07% -3.05% -2.03% 0.29% -6.26%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
33.56% 33.27% 37.95% 36.67% 35.64% 36.76% 36.71% 38.47% 39.13% 39.90% 41.73%
EBITDA Margin
11.89% 11.24% 17.04% 16.72% 15.52% 14.01% 15.89% 26.70% 17.74% 16.22% 26.05%
Operating Margin
9.36% 8.79% 13.12% 12.42% 10.01% 9.02% 12.01% 23.09% 14.12% 11.84% 21.71%
EBIT Margin
9.50% 8.49% 12.83% 12.15% 10.18% 8.94% 11.85% 22.85% 13.83% 11.74% 21.72%
Profit (Net Income) Margin
6.93% 7.18% 6.15% 10.61% 3.34% 5.56% 8.35% 18.76% 10.14% 7.30% 14.42%
Tax Burden Percent
75.97% 91.34% 53.52% 101.40% 37.33% 69.21% 75.52% 84.78% 76.82% 83.83% 78.89%
Interest Burden Percent
95.98% 92.65% 89.49% 86.16% 87.86% 89.79% 93.26% 96.81% 95.44% 74.20% 84.14%
Effective Tax Rate
23.78% 23.20% 55.60% 27.90% 24.15% 26.86% 24.37% 15.12% 22.64% 16.11% 21.02%
Return on Invested Capital (ROIC)
15.46% 10.27% 7.18% 11.50% 8.48% 7.80% 11.73% 25.16% 13.10% 8.70% 13.40%
ROIC Less NNEP Spread (ROIC-NNEP)
27.91% 18.06% 10.77% 37.51% -24.37% -1.83% 3.63% -0.92% 53.95% -0.69% 7.21%
Return on Net Nonoperating Assets (RNNOA)
-0.97% 1.69% 1.33% 3.35% -4.12% -0.27% 0.48% -0.04% -1.21% -0.23% 3.80%
Return on Equity (ROE)
14.49% 11.96% 8.52% 14.84% 4.36% 7.54% 12.21% 25.12% 11.89% 8.48% 17.20%
Cash Return on Invested Capital (CROIC)
19.77% -30.33% 19.24% -6.36% 9.08% 2.41% 11.77% 22.41% 7.94% -54.65% 21.56%
Operating Return on Assets (OROA)
10.58% 7.06% 8.56% 8.45% 6.64% 6.20% 9.19% 17.29% 9.82% 7.21% 12.29%
Return on Assets (ROA)
7.71% 5.97% 4.10% 7.39% 2.18% 3.85% 6.47% 14.19% 7.20% 4.49% 8.15%
Return on Common Equity (ROCE)
14.49% 11.96% 8.52% 14.84% 4.36% 7.54% 12.21% 25.12% 11.89% 8.30% 16.88%
Return on Equity Simple (ROE_SIMPLE)
14.07% 11.39% 8.12% 14.63% 4.37% 7.20% 12.29% 22.88% 11.76% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
54 44 35 57 46 43 67 145 79 78 153
NOPAT Margin
7.13% 6.75% 5.83% 8.95% 7.59% 6.59% 9.08% 19.60% 10.92% 9.93% 17.15%
Net Nonoperating Expense Percent (NNEP)
-12.44% -7.79% -3.59% -26.01% 32.86% 9.63% 8.09% 26.07% -40.84% 9.40% 6.19%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - 6.21% 12.01%
Cost of Revenue to Revenue
66.44% 66.73% 62.05% 63.33% 64.36% 63.24% 63.29% 61.53% 60.87% 60.10% 58.27%
SG&A Expenses to Revenue
22.65% 22.39% 23.62% 23.49% 24.56% 24.85% 23.10% 23.26% 23.53% 24.47% 24.60%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
24.20% 24.48% 24.83% 24.25% 25.63% 27.75% 24.70% 15.38% 25.01% 28.06% 20.01%
Earnings before Interest and Taxes (EBIT)
71 55 76 78 62 59 87 169 100 93 194
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
89 73 101 107 94 92 117 198 128 128 232
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.65 2.64 2.73 1.89 1.49 2.24 2.01 2.75 3.07 2.65 5.73
Price to Tangible Book Value (P/TBV)
5.69 16.97 7.99 12.21 8.17 8.75 6.91 6.26 7.29 0.00 0.00
Price to Revenue (P/Rev)
1.30 1.66 2.07 1.37 1.14 1.73 1.37 2.26 2.65 2.39 4.86
Price to Earnings (P/E)
18.81 23.14 33.62 12.91 33.99 31.05 16.38 12.03 26.09 33.88 41.37
Dividend Yield
0.71% 0.73% 0.73% 1.13% 1.56% 1.02% 1.22% 0.78% 0.55% 0.81% 0.38%
Earnings Yield
5.32% 4.32% 2.97% 7.74% 2.94% 3.22% 6.10% 8.31% 3.83% 2.95% 2.42%
Enterprise Value to Invested Capital (EV/IC)
2.80 2.31 2.90 1.81 1.42 2.10 1.89 2.82 3.09 1.99 4.27
Enterprise Value to Revenue (EV/Rev)
1.26 1.82 2.21 1.53 1.27 1.82 1.46 2.23 2.64 2.99 5.24
Enterprise Value to EBITDA (EV/EBITDA)
10.62 16.21 12.96 9.17 8.17 13.01 9.21 8.34 14.88 18.45 20.09
Enterprise Value to EBIT (EV/EBIT)
13.29 21.46 17.21 12.62 12.45 20.37 12.34 9.74 19.08 25.50 24.11
Enterprise Value to NOPAT (EV/NOPAT)
17.70 27.00 37.90 17.13 16.70 27.63 16.11 11.36 24.16 30.13 30.53
Enterprise Value to Operating Cash Flow (EV/OCF)
11.82 18.61 20.25 13.38 16.23 14.30 13.84 18.17 20.52 33.98 52.12
Enterprise Value to Free Cash Flow (EV/FCFF)
13.84 0.00 14.15 0.00 15.60 89.42 16.06 12.75 39.85 0.00 18.97
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.25 0.47 0.43 0.43 0.43 0.39 0.35 0.29 0.24 0.75 0.69
Long-Term Debt to Equity
0.25 0.47 0.43 0.43 0.43 0.39 0.35 0.29 0.24 0.75 0.69
Financial Leverage
-0.03 0.09 0.12 0.09 0.17 0.15 0.13 0.04 -0.02 0.33 0.53
Leverage Ratio
1.88 2.00 2.08 2.01 2.00 1.96 1.89 1.77 1.65 1.89 2.11
Compound Leverage Factor
1.80 1.85 1.86 1.73 1.76 1.76 1.76 1.71 1.58 1.40 1.77
Debt to Total Capital
19.93% 31.96% 30.06% 29.85% 30.14% 28.26% 25.93% 22.21% 19.33% 42.76% 40.68%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
19.93% 31.96% 30.06% 29.85% 30.14% 28.26% 25.93% 22.21% 19.33% 42.76% 40.68%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.16% 0.00%
Common Equity to Total Capital
80.07% 68.04% 69.94% 70.15% 69.86% 71.74% 74.07% 77.79% 80.68% 55.08% 59.32%
Debt to EBITDA
1.03 2.64 1.91 1.85 2.12 2.17 1.50 0.88 1.16 4.31 2.23
Net Debt to EBITDA
-0.33 1.42 0.83 0.98 0.86 0.69 0.60 -0.11 -0.04 3.49 1.46
Long-Term Debt to EBITDA
1.03 2.64 1.91 1.85 2.12 2.17 1.50 0.88 1.16 4.31 2.23
Debt to NOPAT
1.72 4.39 5.58 3.45 4.34 4.61 2.62 1.19 1.89 7.04 3.39
Net Debt to NOPAT
-0.56 2.37 2.43 1.82 1.75 1.46 1.05 -0.15 -0.07 5.71 2.22
Long-Term Debt to NOPAT
1.72 4.39 5.58 3.45 4.34 4.61 2.62 1.19 1.89 7.04 3.39
Altman Z-Score
5.02 3.80 3.96 3.62 3.26 3.90 4.13 5.47 5.90 3.32 5.41
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.05% 1.87%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.65 2.26 2.38 2.36 2.70 2.61 2.51 3.43 3.37 2.88 2.40
Quick Ratio
1.68 1.35 1.42 1.39 1.77 1.71 1.47 2.26 2.16 1.66 1.53
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
69 -129 93 -32 49 13 67 129 48 -493 246
Operating Cash Flow to CapEx
459.84% 260.52% 313.42% 249.96% 221.37% 386.33% 352.12% 403.06% 456.48% 249.40% 355.42%
Free Cash Flow to Firm to Interest Expense
23.88 -31.93 11.57 -2.95 6.57 2.23 11.41 23.93 10.50 -20.60 8.01
Operating Cash Flow to Interest Expense
27.98 15.69 8.09 6.82 6.32 13.95 13.23 16.80 20.39 2.91 2.92
Operating Cash Flow Less CapEx to Interest Expense
21.89 9.67 5.51 4.09 3.47 10.34 9.47 12.63 15.92 1.74 2.10
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.11 0.83 0.67 0.70 0.65 0.69 0.78 0.76 0.71 0.61 0.57
Accounts Receivable Turnover
7.01 5.61 4.83 5.74 6.00 6.31 6.48 6.16 5.89 5.37 5.16
Inventory Turnover
4.67 3.85 3.30 4.49 4.82 4.69 4.72 4.47 4.73 4.37 4.01
Fixed Asset Turnover
6.98 5.40 4.41 4.72 4.53 4.94 5.61 5.71 5.42 5.35 5.69
Accounts Payable Turnover
6.33 4.98 4.21 6.09 7.13 6.40 6.24 6.37 6.65 6.27 6.18
Days Sales Outstanding (DSO)
52.07 65.08 75.65 63.64 60.84 57.86 56.33 59.23 62.00 67.92 70.74
Days Inventory Outstanding (DIO)
78.11 94.90 110.48 81.33 75.67 77.80 77.33 81.60 77.24 83.44 90.96
Days Payable Outstanding (DPO)
57.70 73.28 86.65 59.96 51.18 57.03 58.54 57.29 54.91 58.17 59.05
Cash Conversion Cycle (CCC)
72.48 86.70 99.49 85.01 85.33 78.63 75.12 83.55 84.33 93.19 102.65
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
339 512 454 543 540 570 569 585 616 1,188 1,094
Invested Capital Turnover
2.17 1.52 1.23 1.28 1.12 1.18 1.29 1.28 1.20 0.88 0.78
Increase / (Decrease) in Invested Capital
-15 173 -58 89 -3.22 30 -0.22 16 31 571 -93
Enterprise Value (EV)
949 1,180 1,315 981 767 1,196 1,076 1,650 1,901 2,365 4,668
Market Capitalization
979 1,077 1,231 877 686 1,132 1,006 1,672 1,907 1,889 4,329
Book Value per Share
$28.89 $32.06 $35.13 $36.70 $37.20 $41.30 $41.37 $51.03 $52.43 $58.95 $62.34
Tangible Book Value per Share
$13.45 $4.98 $12.01 $5.68 $6.77 $10.56 $12.07 $22.43 $22.07 ($10.31) ($2.13)
Total Capital
462 601 645 662 661 706 674 781 770 1,292 1,273
Total Debt
92 192 194 198 199 199 175 173 149 553 518
Total Long-Term Debt
92 192 194 198 199 199 175 173 149 553 518
Net Debt
-30 103 84 104 80 63 70 -22 -5.33 448 339
Capital Expenditures (CapEx)
17 24 21 29 21 22 22 23 20 28 25
Debt-free, Cash-free Net Working Capital (DFCFNWC)
100 112 113 99 90 94 123 147 148 209 144
Debt-free Net Working Capital (DFNWC)
222 201 223 192 209 231 228 342 303 314 322
Net Working Capital (NWC)
222 201 223 192 209 231 228 342 303 314 322
Net Nonoperating Expense (NNE)
1.56 -2.83 -1.91 -11 26 6.80 5.39 6.22 5.63 21 24
Net Nonoperating Obligations (NNO)
-31 103 3.06 79 78 63 70 -22 -5.33 448 339
Total Depreciation and Amortization (D&A)
18 18 25 29 32 33 30 28 28 35 39
Debt-free, Cash-free Net Working Capital to Revenue
13.27% 17.34% 18.98% 15.49% 14.94% 14.37% 16.78% 19.78% 20.58% 26.50% 16.10%
Debt-free Net Working Capital to Revenue
29.50% 31.01% 37.38% 30.04% 34.59% 35.15% 31.04% 46.19% 41.98% 39.73% 36.14%
Net Working Capital to Revenue
29.50% 31.01% 37.38% 30.04% 34.59% 35.15% 31.04% 46.19% 41.98% 39.73% 36.14%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$4.11 $3.68 $2.88 $5.40 $1.64 $3.00 $5.13 $11.77 $6.22 $4.68 $8.69
Adjusted Weighted Average Basic Shares Outstanding
12.78M 12.78M 12.83M 12.45M 12.38M 12.21M 11.97M 11.85M 11.85M 12.07M 12.12M
Adjusted Diluted Earnings per Share
$4.08 $3.65 $2.86 $5.38 $1.63 $2.97 $5.06 $11.58 $6.14 $4.64 $8.67
Adjusted Weighted Average Diluted Shares Outstanding
12.78M 12.78M 12.83M 12.45M 12.38M 12.21M 11.97M 11.85M 11.85M 12.07M 12.12M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
12.78M 12.78M 12.83M 12.45M 12.38M 12.21M 11.97M 11.85M 11.85M 12.07M 12.12M
Normalized Net Operating Profit after Tax (NOPAT)
57 54 60 60 51 57 71 96 87 102 166
Normalized NOPAT Margin
7.56% 8.36% 10.03% 9.45% 8.40% 8.72% 9.70% 12.99% 12.06% 12.94% 18.59%
Pre Tax Income Margin
9.12% 7.87% 11.48% 10.47% 8.94% 8.03% 11.05% 22.12% 13.20% 8.71% 18.28%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
24.87 13.60 9.52 7.22 8.23 9.80 14.84 31.33 21.93 3.88 6.31
NOPAT to Interest Expense
18.68 10.81 4.32 5.33 6.14 7.22 11.37 26.87 17.32 3.28 4.98
EBIT Less CapEx to Interest Expense
18.78 7.58 6.94 4.50 5.38 6.18 11.08 27.16 17.47 2.71 5.48
NOPAT Less CapEx to Interest Expense
12.59 4.79 1.74 2.60 3.29 3.61 7.61 22.70 12.85 2.11 4.16
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
13.15% 16.87% 24.28% 14.47% 52.54% 31.39% 19.95% 9.34% 19.02% 26.06% 14.71%
Augmented Payout Ratio
23.98% 33.64% 31.53% 63.64% 104.24% 89.52% 71.14% 27.71% 62.57% 43.23% 18.14%

Quarterly Metrics And Ratios for Standex International

This table displays calculated financial ratios and metrics derived from Standex International's official financial filings.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - 12,116,999.00 12,118,733.00 12,114,922.00 12,119,465.00
DEI Adjusted Shares Outstanding
- - - - - - - 12,116,999.00 12,118,733.00 12,114,922.00 12,119,465.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - 0.18 5.53 1.69 1.99
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-3.83% -4.32% -7.74% 6.40% 17.21% 23.23% 27.55% 16.60% 8.09% 2.79% 6.97%
EBITDA Growth
-70.14% -4.94% -5.93% -50.36% 25.70% 32.43% 27.34% 180.30% 178.65% 6.31% 23.20%
EBIT Growth
-75.83% -5.47% -7.46% -70.30% 22.29% 29.25% 23.92% 363.26% 246.89% 10.19% 31.72%
NOPAT Growth
-79.20% -1.14% -7.68% -72.89% 98.00% -1.38% 18.00% 395.18% 121.69% 33.92% 36.30%
Net Income Growth
-80.38% -2.87% -3.28% -93.24% 43.85% -20.95% -13.20% 1,522.04% 201.49% 52.07% 53.00%
EPS Growth
-80.35% 3.14% -3.16% -95.60% 36.09% -25.00% -18.30% 142.86% 206.63% 38.21% 58.40%
Operating Cash Flow Growth
4.68% -29.49% 8.61% -61.56% -60.85% 17.10% -4.25% 126.96% 23.13% 20.97% -7.34%
Free Cash Flow Firm Growth
-111.28% -291.31% 17.80% -3,192.43% -6,275.87% -5,353.96% -7,137.84% 87.13% 117.65% 121.92% 106.25%
Invested Capital Growth
4.20% 5.30% 4.23% 74.83% 88.27% 92.73% 83.80% 7.91% -1.40% -7.84% -0.15%
Revenue Q/Q Growth
-0.64% 1.65% -5.40% 11.35% 9.47% 6.87% -2.08% 1.79% 1.48% 1.63% 1.89%
EBITDA Q/Q Growth
-12.34% 19.31% -7.93% -48.45% 121.97% 26.72% -12.18% 13.47% 120.66% -51.65% 1.77%
EBIT Q/Q Growth
-16.80% 26.71% -10.25% -68.61% 242.59% 35.28% -14.81% 17.34% 156.53% -57.03% 1.83%
NOPAT Q/Q Growth
-14.64% 21.62% -9.38% -71.19% 523.46% -39.42% 8.42% 20.92% 179.12% -63.40% 10.35%
Net Income Q/Q Growth
-16.28% 24.01% -7.12% -92.99% 1,682.43% -31.86% 2.00% 30.93% 231.30% -65.63% 2.62%
EPS Q/Q Growth
-16.35% 23.31% -6.71% -95.42% 2,485.71% -32.04% 1.63% -86.40% 3,164.71% -69.37% 16.47%
Operating Cash Flow Q/Q Growth
3.40% 17.14% -38.44% -48.46% 5.32% 250.36% -49.66% 22.18% -42.86% 244.19% -61.44%
Free Cash Flow Firm Q/Q Growth
41.95% -23.55% 29.40% -6,402.04% -12.42% -5.69% 6.31% 88.44% 254.20% 31.26% -73.30%
Invested Capital Q/Q Growth
0.34% -2.03% 4.26% 70.58% 8.06% 0.29% -0.57% 0.14% -1.27% -6.26% 7.73%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
38.52% 38.52% 41.11% 37.64% 39.67% 41.12% 41.59% 41.67% 40.93% 42.69% 44.37%
EBITDA Margin
16.02% 18.80% 18.30% 8.47% 17.18% 20.37% 18.27% 20.36% 44.28% 21.06% 21.04%
Operating Margin
12.32% 15.07% 14.14% 4.46% 12.64% 15.64% 13.63% 16.07% 40.44% 16.45% 17.38%
EBIT Margin
11.97% 14.92% 14.15% 3.99% 12.49% 15.81% 13.75% 15.85% 40.07% 16.94% 16.93%
Profit (Net Income) Margin
8.91% 10.87% 10.68% 0.67% 10.94% 6.97% 7.26% 9.34% 30.51% 10.32% 10.39%
Tax Burden Percent
77.95% 76.58% 78.60% 63.81% 129.26% 59.38% 75.26% 76.12% 82.88% 73.33% 75.15%
Interest Burden Percent
95.53% 95.16% 95.95% 26.38% 67.77% 74.31% 70.19% 77.44% 91.86% 83.04% 81.66%
Effective Tax Rate
21.35% 23.04% 21.43% 35.54% -29.56% 40.68% 24.61% 24.06% 16.98% 26.51% 24.66%
Return on Invested Capital (ROIC)
11.46% 13.91% 12.46% 2.40% 13.51% 8.13% 9.43% 9.31% 25.28% 9.45% 10.06%
ROIC Less NNEP Spread (ROIC-NNEP)
-22.98% 23.35% -11.60% 0.40% 8.80% 5.82% 6.39% 7.82% 23.64% 8.42% 8.58%
Return on Net Nonoperating Assets (RNNOA)
-0.15% -0.52% -0.06% 0.13% 3.17% 1.89% 1.98% 4.66% 13.10% 4.43% 4.80%
Return on Equity (ROE)
11.31% 13.39% 12.41% 2.52% 16.68% 10.02% 11.41% 13.97% 38.39% 13.88% 14.87%
Cash Return on Invested Capital (CROIC)
8.69% 7.94% 8.11% -47.10% -52.64% -54.65% -50.03% 1.41% 13.88% 21.56% 13.79%
Operating Return on Assets (OROA)
8.68% 10.59% 9.90% 2.30% 7.33% 9.71% 8.88% 9.07% 23.03% 9.58% 9.92%
Return on Assets (ROA)
6.47% 7.72% 7.47% 0.39% 6.42% 4.29% 4.69% 5.34% 17.53% 5.84% 6.09%
Return on Common Equity (ROCE)
11.31% 13.39% 12.41% 2.47% 16.33% 9.82% 11.19% 13.27% 36.56% 13.62% 14.60%
Return on Equity Simple (ROE_SIMPLE)
11.90% 0.00% 11.01% 8.36% 9.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
17 21 19 5.46 34 21 22 27 75 28 30
NOPAT Margin
9.69% 11.59% 11.11% 2.87% 16.37% 9.28% 10.28% 12.21% 33.57% 12.09% 13.09%
Net Nonoperating Expense Percent (NNEP)
34.44% -9.44% 24.07% 1.99% 4.71% 2.31% 3.04% 1.49% 1.64% 1.03% 1.48%
Return On Investment Capital (ROIC_SIMPLE)
- - - 0.46% 2.69% 1.63% 1.78% 2.19% 6.15% 2.17% 2.35%
Cost of Revenue to Revenue
61.48% 61.48% 58.89% 62.36% 60.33% 58.88% 58.41% 58.33% 59.07% 57.31% 55.63%
SG&A Expenses to Revenue
23.56% 22.74% 25.25% 24.06% 25.05% 23.69% 25.01% 25.12% 23.35% 24.92% 26.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
26.20% 23.46% 26.97% 33.18% 27.04% 25.47% 27.96% 25.60% 0.49% 26.24% 26.99%
Earnings before Interest and Taxes (EBIT)
21 27 24 7.57 26 35 30 35 90 39 39
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
28 34 31 16 36 45 40 45 99 48 49
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.48 3.07 3.29 3.44 2.80 2.65 3.61 0.00 4.10 5.73 4.25
Price to Tangible Book Value (P/TBV)
8.45 7.29 7.55 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1,398.71
Price to Revenue (P/Rev)
2.96 2.65 3.07 3.15 2.57 2.39 3.06 0.00 3.49 4.86 3.65
Price to Earnings (P/E)
29.27 26.09 29.90 41.50 31.73 33.88 48.60 0.00 31.20 41.37 29.10
Dividend Yield
0.47% 0.55% 0.49% 0.65% 0.77% 0.81% 0.60% 0.60% 0.52% 0.38% 0.50%
Earnings Yield
3.42% 3.83% 3.34% 2.41% 3.15% 2.95% 2.06% 0.00% 3.20% 2.42% 3.44%
Enterprise Value to Invested Capital (EV/IC)
3.44 3.09 3.35 2.46 2.04 1.99 2.57 0.00 3.00 4.27 3.15
Enterprise Value to Revenue (EV/Rev)
2.97 2.64 3.05 3.76 3.23 2.99 3.62 0.00 3.96 5.24 4.09
Enterprise Value to EBITDA (EV/EBITDA)
16.71 14.88 17.09 24.64 20.69 18.45 22.17 0.00 15.26 20.09 15.36
Enterprise Value to EBIT (EV/EBIT)
21.39 19.08 22.01 33.82 28.60 25.50 30.76 0.00 18.42 24.11 18.27
Enterprise Value to NOPAT (EV/NOPAT)
27.43 24.16 27.89 42.64 31.01 30.13 36.82 0.00 23.89 30.53 23.06
Enterprise Value to Operating Cash Flow (EV/OCF)
20.70 20.52 22.87 33.93 37.35 33.98 44.02 0.00 42.42 52.12 42.01
Enterprise Value to Free Cash Flow (EV/FCFF)
40.41 39.85 42.12 0.00 0.00 0.00 0.00 0.00 21.46 18.97 22.81
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.24 0.24 0.23 0.78 0.81 0.75 0.74 0.72 0.59 0.69 0.67
Long-Term Debt to Equity
0.24 0.24 0.23 0.78 0.81 0.75 0.74 0.72 0.59 0.69 0.67
Financial Leverage
0.01 -0.02 0.00 0.32 0.36 0.33 0.31 0.60 0.55 0.53 0.56
Leverage Ratio
1.64 1.65 1.61 1.91 1.91 1.89 1.86 2.13 2.04 2.11 2.05
Compound Leverage Factor
1.57 1.57 1.55 0.50 1.29 1.40 1.31 1.65 1.87 1.75 1.67
Debt to Total Capital
19.38% 19.33% 18.46% 43.90% 44.78% 42.76% 42.57% 41.79% 37.20% 40.68% 39.98%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
19.38% 19.33% 18.46% 43.90% 44.78% 42.76% 42.57% 41.79% 37.20% 40.68% 39.98%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 2.19% 2.13% 2.16% 2.12% 3.48% 3.48% 0.00% 0.00%
Common Equity to Total Capital
80.62% 80.68% 81.54% 53.91% 53.09% 55.08% 55.31% 54.73% 59.33% 59.32% 60.02%
Debt to EBITDA
1.15 1.16 1.18 4.88 4.96 4.31 3.98 3.23 2.06 2.23 2.15
Net Debt to EBITDA
0.08 -0.04 -0.12 3.77 4.02 3.49 3.26 2.64 1.61 1.46 1.66
Long-Term Debt to EBITDA
1.15 1.16 1.18 4.88 4.96 4.31 3.98 3.23 2.06 2.23 2.15
Debt to NOPAT
1.88 1.89 1.93 8.44 7.43 7.04 6.62 5.21 3.23 3.39 3.22
Net Debt to NOPAT
0.13 -0.07 -0.20 6.53 6.02 5.71 5.42 4.26 2.52 2.22 2.49
Long-Term Debt to NOPAT
1.88 1.89 1.93 8.44 7.43 7.04 6.62 5.21 3.23 3.39 3.22
Altman Z-Score
6.12 5.66 6.04 3.50 3.18 3.20 3.74 0.00 4.67 5.09 4.68
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 2.04% 2.07% 2.05% 1.95% 4.98% 4.75% 1.87% 1.79%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.43 3.37 3.55 3.37 3.40 2.88 2.87 2.87 3.05 2.40 3.19
Quick Ratio
2.12 2.16 2.25 1.99 1.95 1.66 1.56 1.60 1.79 1.53 1.77
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-8.17 -10 -7.13 -464 -521 -551 -516 -60 92 121 32
Operating Cash Flow to CapEx
470.59% 436.92% 261.31% 130.05% 157.11% 389.51% 262.09% 268.24% 210.14% 731.80% 237.56%
Free Cash Flow to Firm to Interest Expense
-8.61 -7.77 -7.30 -83.15 -62.31 -61.09 -57.90 -7.54 12.55 18.41 4.46
Operating Cash Flow to Interest Expense
25.68 21.96 17.99 1.62 1.14 3.71 1.89 2.60 1.60 6.17 2.16
Operating Cash Flow Less CapEx to Interest Expense
20.22 16.93 11.10 0.38 0.41 2.76 1.17 1.63 0.84 5.32 1.25
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.73 0.71 0.70 0.58 0.59 0.61 0.65 0.57 0.57 0.57 0.59
Accounts Receivable Turnover
6.03 5.89 5.75 5.15 5.15 5.37 5.87 5.27 5.07 5.16 5.41
Inventory Turnover
4.43 4.73 4.53 4.33 4.23 4.37 4.44 4.36 4.16 4.01 3.75
Fixed Asset Turnover
5.49 5.42 5.28 5.31 5.31 5.35 5.62 5.83 5.92 5.69 5.79
Accounts Payable Turnover
7.03 6.65 6.64 6.39 6.74 6.27 6.50 6.36 6.75 6.18 6.25
Days Sales Outstanding (DSO)
60.52 62.00 63.53 70.88 70.82 67.92 62.22 69.30 72.05 70.74 67.48
Days Inventory Outstanding (DIO)
82.35 77.24 80.55 84.31 86.31 83.44 82.21 83.80 87.66 90.96 97.37
Days Payable Outstanding (DPO)
51.94 54.91 54.97 57.13 54.14 58.17 56.12 57.42 54.05 59.05 58.43
Cash Conversion Cycle (CCC)
90.92 84.33 89.11 98.05 103.00 93.19 88.31 95.67 105.67 102.65 106.41
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
629 616 642 1,096 1,184 1,188 1,181 1,182 1,168 1,094 1,179
Invested Capital Turnover
1.18 1.20 1.12 0.83 0.83 0.88 0.92 0.76 0.75 0.78 0.77
Increase / (Decrease) in Invested Capital
25 31 26 469 555 571 538 87 -17 -93 -1.79
Enterprise Value (EV)
2,165 1,901 2,151 2,699 2,417 2,365 3,030 0.00 3,502 4,668 3,711
Market Capitalization
2,155 1,907 2,167 2,259 1,920 1,889 2,557 0.00 3,089 4,329 3,309
Book Value per Share
$52.14 $52.43 $55.51 $54.30 $57.73 $58.95 $58.91 $58.14 $62.23 $62.34 $64.18
Tangible Book Value per Share
$21.49 $22.07 $24.20 ($11.44) ($12.66) ($10.31) ($9.19) ($8.79) ($2.99) ($2.13) $0.20
Total Capital
768 770 807 1,217 1,294 1,292 1,279 1,279 1,271 1,273 1,296
Total Debt
149 149 149 534 579 553 545 535 473 518 518
Total Long-Term Debt
149 149 149 534 579 553 545 535 473 518 518
Net Debt
9.97 -5.33 -16 413 470 448 446 438 369 339 401
Capital Expenditures (CapEx)
5.18 6.53 6.73 6.97 6.07 8.58 6.42 7.66 5.59 5.53 6.56
Debt-free, Cash-free Net Working Capital (DFCFNWC)
158 148 157 206 234 209 219 223 221 144 236
Debt-free Net Working Capital (DFNWC)
297 303 321 327 344 314 318 320 324 322 352
Net Working Capital (NWC)
297 303 321 327 344 314 318 320 324 322 352
Net Nonoperating Expense (NNE)
1.38 1.30 0.74 4.18 11 5.12 6.55 6.33 6.89 4.04 6.28
Net Nonoperating Obligations (NNO)
9.97 -5.33 -16 413 470 448 446 438 369 339 401
Total Depreciation and Amortization (D&A)
7.18 6.99 7.06 8.51 9.74 10 9.82 9.98 9.45 9.40 9.55
Debt-free, Cash-free Net Working Capital to Revenue
21.68% 20.58% 22.17% 28.65% 31.27% 26.50% 26.19% 25.67% 24.91% 16.10% 25.98%
Debt-free Net Working Capital to Revenue
40.73% 41.98% 45.47% 45.53% 45.95% 39.73% 37.97% 36.83% 36.63% 36.14% 38.87%
Net Working Capital to Revenue
40.73% 41.98% 45.47% 45.53% 45.95% 39.73% 37.97% 36.83% 36.63% 36.14% 38.87%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.34 $1.68 $1.54 $0.07 $1.83 $1.24 $1.26 $0.17 $5.56 $1.70 $2.00
Adjusted Weighted Average Basic Shares Outstanding
11.77M 11.85M 11.79M 11.94M 11.99M 12.07M 12.01M 12.04M 12.05M 12.12M 12.07M
Adjusted Diluted Earnings per Share
$1.33 $1.64 $1.53 $0.07 $1.81 $1.23 $1.25 $0.17 $5.55 $1.70 $1.98
Adjusted Weighted Average Diluted Shares Outstanding
11.85M 11.85M 11.90M 12.03M 12.06M 12.07M 12.05M 12.06M 12.06M 12.12M 12.15M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
11.85M 11.85M 12.08M 11.90M 12.07M 12.07M 12.12M 12.12M 12.11M 12.12M 12.10M
Normalized Net Operating Profit after Tax (NOPAT)
21 22 21 17 21 23 27 28 80 30 32
Normalized NOPAT Margin
11.72% 12.15% 12.46% 8.76% 10.24% 10.34% 12.50% 12.57% 35.61% 13.14% 13.55%
Pre Tax Income Margin
11.43% 14.20% 13.58% 1.05% 8.46% 11.75% 9.65% 12.28% 36.81% 14.07% 13.83%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
22.36 20.68 24.70 1.36 3.10 3.89 3.35 4.43 12.28 5.90 5.45
NOPAT to Interest Expense
18.10 16.07 19.38 0.98 4.07 2.29 2.51 3.41 10.29 4.21 4.22
EBIT Less CapEx to Interest Expense
16.90 15.65 17.81 0.11 2.38 2.94 2.63 3.46 11.52 5.05 4.54
NOPAT Less CapEx to Interest Expense
12.65 11.05 12.50 -0.27 3.34 1.33 1.79 2.45 9.53 3.37 3.31
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
18.55% 19.02% 19.52% 26.29% 23.83% 26.06% 29.06% 23.03% 15.19% 14.71% 60.17%
Augmented Payout Ratio
71.13% 62.57% 38.91% 53.19% 39.41% 43.23% 45.82% 28.55% 18.61% 18.14% 63.78%

Financials Breakdown Chart

Key Financial Trends

Standex International’s latest quarter showed stronger sales and profitability. For Q1 fiscal 2027, ended September 30, 2026, revenue rose 7.0% from the year-earlier quarter to $232.6 million. Gross profit increased to $103.2 million, lifting the gross margin to about 44.4% from 41.6%. Operating income grew to $40.4 million from $29.6 million, while net income attributable to common shareholders climbed to $24.2 million from $15.1 million. Diluted earnings per share increased to $1.98 from $1.25.

The longer-term figures also point to a larger business than in 2023–2024, though acquisitions materially changed Standex’s scale and balance sheet. The main considerations for investors are whether recent earnings gains translate into stronger cash generation and how the company manages acquisition-related debt and intangible assets.

  • Revenue growth has continued. Quarterly revenue reached $232.6 million, up from $217.4 million in Q1 fiscal 2026 and well above the roughly $170 million to $190 million quarterly levels reported in much of 2023–2024.
  • Profitability improved year over year. Q1 fiscal 2027 operating income rose about 36% year over year, and common-shareholder earnings increased about 61%. The gross margin also expanded by roughly 2.8 percentage points.
  • Liquidity remains solid. Standex reported $513.3 million in current assets against $160.8 million in current liabilities, a current ratio of about 3.2. Cash of $116.8 million was also higher than the $98.7 million reported at September 2025.
  • Debt has eased from its recent peak. Long-term debt declined to $518.1 million from $544.6 million a year earlier and from $579.4 million in March 2025, indicating some progress in reducing borrowings.
  • Cash generation did not keep pace with earnings. Operating cash flow was $15.6 million in Q1 fiscal 2027, versus $16.8 million a year earlier. After $6.6 million of capital spending, estimated free cash flow was about $9.1 million, down from roughly $10.4 million.
  • Some reported quarters are difficult to compare. Q3 fiscal 2026 included a large negative “other operating expenses” entry that substantially boosted reported operating income. That unusual item makes the quarter’s earnings and EPS less representative of the underlying trend.
  • Working capital was a significant cash-flow drag. Changes in operating assets and liabilities used $22.5 million in Q1 fiscal 2027, compared with a $1.3 million use in the year-earlier quarter. This largely explains why operating cash flow fell despite higher net income.
  • Acquisition-related leverage remains elevated. Long-term debt of $518.1 million is well above the roughly $149 million reported in September 2024, while goodwill and intangible assets total about $775 million—around half of total assets. Debt has come down from its peak, but leverage and the value of acquired assets remain important risks to monitor.
  • The latest cash-flow statement reports an unusually large dividend payment. Q1 fiscal 2027 financing cash flow lists $68.0 million of dividends, far above the roughly $4 million to $5 million quarterly payments shown in most prior periods. This contributed to a $71.5 million financing cash outflow and a $61.9 million net decrease in cash during the quarter; investors may want to check the filing for context on this outlier.
11/18/26 01:57 PM ETAI Generated. May Contain Errors.

Standex International Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Standex International's fiscal year ends in June. Their fiscal year 2026 ended on June 30, 2026.

Standex International's net income appears to be on an upward trend, with a most recent value of $128.54 million in 2026, rising from $52.06 million in 2016. The previous period was $57.68 million in 2025. Check out Standex International's forecast to explore projected trends and price targets.

Standex International's total operating income in 2026 was $193.58 million, based on the following breakdown:
  • Total Gross Profit: $372.03 million
  • Total Operating Expenses: $178.45 million

Over the last 10 years, Standex International's total revenue changed from $751.59 million in 2016 to $891.60 million in 2026, a change of 18.6%.

In the past 14 quarters, Standex International's cash and equivalents has ranged from $97.00 million in Q2 2026 to $175.28 million in Q3 2023, and is currently $116.84 million as of their latest financial filing in Q1 2027.

Standex International had total debt of $517.95 million at the end of 2026, a 6.3% decrease from 2025, and a 462.3% increase since 2016.

Over the last 10 years, Standex International's book value per share changed from 28.89 in 2016 to 62.34 in 2026, a change of 115.8%.



Financial statements for NYSE:SXI last updated on 10/30/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners